XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.22.4

Earnings Per Share ("EPS") | 9 Months Ended
--- | ---
Jan. 28, 2023
Earnings Per Share [Abstract] |
Earnings Per Share ("EPS") | Earnings Per Share ("EPS") The following is a reconciliation of the net income (loss) and common share amounts used in the calculation of basic and diluted EPS for the three and nine months ended January 28, 2023 and January 29, 2022:
| Net income (loss) |  | Shares |  | Per share (loss) income
For the three months ended January 28, 2023 |  |  |  |  |
Basic earnings per share | $ | 3,713 |  |  | 45,387 |  |  | $ | 0.08 |
Dilution associated with stock compensation plans | — |  |  | 61 |  |  | — |
Diluted earnings per share | $ | 3,713 |  |  | 45,448 |  |  | $ | 0.08 |
For the three months ended January 29, 2022 |  |  |  |  |
Basic and diluted (loss) earnings per share | $ | (4,350) |  |  | 45,223 |  |  | $ | (0.10) |
Diluted (loss) earnings per share | $ | (4,350) |  |  | 45,223 |  |  | $ | (0.10) |
For the nine months ended January 28, 2023 |  |  |  |  |
Basic and diluted (loss) earnings per share | $ | (14,597) |  |  | 45,320 |  |  | $ | (0.32) |
Diluted (loss) earnings per share | $ | (14,597) |  |  | 45,320 |  |  | $ | (0.32) |
For the nine months ended January 29, 2022 |  |  |  |  |
Basic earnings per share | $ | 1,709 |  |  | 45,263 |  |  | $ | 0.04 |
Dilution associated with stock compensation plans | — |  |  | 179 |  |  | — |
Diluted earnings per share | $ | 1,709 |  |  | 45,442 |  |  | $ | 0.04 |
Options outstanding to purchase 2,102 shares of common stock with a weighted average exercise price of $7.13 for the three months ended January 28, 2023 and 2,216 shares of common stock with a weighted average exercise price of $8.17 for the three months ended January 29, 2022 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive. Options outstanding to purchase 2,089 shares of common stock with a weighted average exercise price of $7.59 for the nine months ended January 28, 2023 and 1,857 shares of common stock with a weighted average exercise price of $9.26 for the nine months ended January 29, 2022 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration